Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Neurolink logo — Pioneering new treatments for Central Nervous System disorde...

Neurolink

Pioneering new treatments for Central Nervous System disorders from San Jose, California.

Founded 2008 22 employees Venture round Total: $3.88M Biotechnology, Health and Wellness +1

General Information

Company Name Neurolink
Founded Year 2008
Employees 22
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Neurolink. To contact Neurolink, visit neurolinkmedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Neurolink

Neurolink, based in San Jose, California, is a biotechnology and pharmaceutical company that has been pioneering new treatments for Central Nervous System (CNS) disorders since its establishment in 2008. The company has received a $2.26M Venture Round investment on 28 December 2010. Neurolink Medical, Inc. is dedicated to developing innovative therapies for CNS disorders and has garnered the attention of venture capitalists seeking to support advancements in this critical field.

Taxonomy: Neurology, Central Nervous System, San Jose, California, Innovation, Medical Research, Neuroscience

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.26M -
28 Dec 2010
Venture Round $1.62M -
18 Oct 2010

Neurolink Alternatives & Competitors

View All Alternatives
Neurolink vs
AGY Therapeutics
AGY Therapeutics

Pioneering breakthrough treatments for central nervous system diseases through innovative gene disco...

Series C
Biopharma, Biotechnology
Neurolink vs
Seelos Therapeutics, Inc.
Seelos Therapeutics, Inc. United States

A clinical-stage biopharmaceutical company focused on central nervous system disorders and rare dise...

Post-IPO Equity
8 employees
Biotechnology, Pharmaceutical
Neurolink vs
Euthymics Bioscience
Euthymics Bioscience

Developing next-gen treatments for depression targeting those unmet by SSRIs

Series A
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Neurolink

Pioneering new treatments for Central Nervous System disorders from San Jose, California.
Neurolink was founded in 2008.
Neurolink operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on Neurology, Central Nervous System, San Jose and California.
Neurolink has approximately 22 employees.
Neurolink has completed 2 funding rounds, raising a total of $3.88M. The latest funding stage is Venture round.
Top alternatives and competitors to Neurolink include AGY Therapeutics, Seelos Therapeutics, Inc., Euthymics Bioscience, Civitas Therapeutics, ICB International. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurolink and AGY Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neurolink, https://bouncewatch.com/company/neurolink, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes